Kai Xu

Research interests

Publications

• Enhanced neutralization resistance of SARS-CoV-2 Omicron subvariants BQ.1, BQ.1.1, BA.4.6, BF.7, and BA.2.75.2

  Cell Host & Microbe · 2022 · 10.1016/j.chom.2022.11.012

• Nanobodies from camelid mice and llamas neutralize SARS-CoV-2 variants

  Nature · 2021 · https://doi.org/10.1038/s41586-021-03676-z

• Epitope-based vaccine design yields fusion peptide-directed antibodies that neutralize diverse strains of HIV-1

  Nature Medicine · 2018 · 10.1038/s41591-018-0042-6

• Quantification of the Impact of the HIV-1-Glycan Shield on Antibody Elicitation

  Cell Reports · 2017 · https://doi.org/10.1016/j.celrep.2017.04.013

• Fusion peptide of HIV-1 as a site of vulnerability to neutralizing antibody

  Science · 2016 · https://doi.org/10.1126/science.aae0474

• Architecture of Eph receptor clusters

  Proceedings of the National Academy of Sciences · 2010 · 10.1073/pnas.1004148107

• Unmutated and mutated chronic lymphocytic leukemias derive from self-reactive B cell precursors despite expressing different antibody reactivity

  Journal of Clinical Investigation · 2005 · 10.1172/jci24387

• Nitric oxide synthase in cardiac sarcoplasmic reticulum

  Proceedings of the National Academy of Sciences · 1999 · 10.1073/pnas.96.2.657

• Hydroxyl Radical Inhibits Sarcoplasmic Reticulum Ca2+-ATPase Function by Direct Attack on the ATP Binding Site

  Circulation Research · 1997 · 10.1161/01.res.80.1.76

Current projects

No projects listed.